TCON Research and Charts

TCON - TRACON Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2024-12-02)

Last 0.03	Change ⇓ -0.01 (0.00%)	Volume 23,886
	Open 0.04	High 0.05	Low 0.03

8EMA (Daily) 0.03	40EMA (Daily) 0.07	50EMA (Daily) 0.09	STO (Daily) 12.500	MACD Hist (Daily) 0.004
8EMA (Weekly) 0.055	40EMA (Weekly) 0.38	50EMA (Weekly) 0.45	STO (Weekly) 5.214	MACD Hist (Weekly) 0.018


Company Profile
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.